GlassScriptPhysician profile
Ha Tran
NPI 1427756204
$2,377.28
in general payments reported to CMS, 2019-2025
18 companies · $978 in 2025
The $978 reported for 2025 was more than what 87% of Acute Care (Nurse Practitioner) providers received nationally (typical 2025 total: $151).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $289 · 2024: $1,110 · 2025: $978.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,376 · Education: $1.25.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,376.03 |
| Education | $1.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sk Life Science, INC. | $723.08 | 2023-2025 | Xcopri |
| Ucb, INC. | $441.69 | 2023-2025 | Briviact, Fintepla |
| Otsuka America Pharmaceutical, INC. | $371.69 | 2024-2025 | Rexulti, Nuedexta |
| Acadia Pharmaceuticals INC | $255.34 | 2024-2025 | Nuplazid |
| Aveo Pharmaceuticals, INC. | $103.10 | 2023 | Fotivda |
| Abbvie INC. | $87.03 | 2024-2025 | |
| Eisai INC. | $70.64 | 2024-2025 | |
| Novartis Pharmaceuticals Corporation | $52.86 | 2023-2024 | |
| Abiomed | $41.73 | 2024 | Impella |
| Pfizer INC. | $40.40 | 2024-2025 | |
| Ossur Americas, INC. | $34.03 | 2025 | Unloader One X |
| Amneal Pharmaceuticals LLC | $31.63 | 2024-2025 | Rytary, Crexont |
| Smith+Nephew, INC. | $27.35 | 2025 | Stravix Pl |
| Biogen, INC. | $21.39 | 2025 | Tysabri, Vumerity |
| Axsome Therapeutics, INC. | $20.95 | 2025 | Symbravo |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $18.65 | 2023 | Verquvo |
| Paratek Pharmaceuticals, INC. | $18.21 | 2025 | Nuzyra |
| Lundbeck LLC | $17.51 | 2025 | Rexulti |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ha Tran listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.